PARP1 and rhabdomyosarcoma: It would also be interesting to examine the possible role of PARP1-dependent chromatin alterations in muscle pathologies, such rhabdomyosarcoma, in which the failure to activate some myogenic targets correlates with the defective MyoD binding to their regulatory regions24.